FDA-Approved Drug Works for Posttraumatic Stress Disorder
At the end of the trial, 53% of the participants had responded to the
medication. "Not only did the medication decrease symptoms significantly
compared to placebo, but also people seemed to be able to live their lives more
fully with this treatment," says Brady.
Sertraline was generally well tolerated by the patients, although insomnia
was a significant problem for 16% of them. Patients also lost more weight with
sertraline than the placebo during the trial.
"In terms of the literature, this is the largest and most conclusive
study yet published, but there are a number of drugs that also show promise.
There's just not as much evidence to support their use as was provided for this
drug," Friedman tells WebMD.
"I'd call the findings exciting but I would not call it a miracle,"
says Tolin. He notes that although patients in the study got better, many
remained symptomatic even after sertraline treatment.
Tolin also points out that other therapies, such as cognitive behavior
therapy, are also helpful for PTSD. He says he expects other companies will
seek FDA approval for their PTSD medications within the next few years. "It
is likely that we'll find different treatments can be used concurrently to
provide maximal effects," says Tolin.
- A new study shows that the antidepressant Zoloft (sertraline) may be
effective against posttraumatic stress disorder (PTSD), improving symptoms,
overall functioning, and quality of life.
- Symptoms did not completely disappear with the drug treatment, and insomnia
was reported as a side effect in some patients.
- Other types of therapy are available to treat PTSD, such as cognitive
behavioral therapy, and a combination of treatments may be the best